IVMatters

IVMatters

Medical Equipment Manufacturing

Huntington, New York 132 followers

Prompt, Actionable & Cost-Effective Development to Commercialization Services for MedTech Companies.

About us

IVMatters supports small to mid-size MedTech companies transition their product development efforts to successful commercialization. We help clients navigate the complex ecosystem of patients, providers, regulators, suppliers, channel partners, insurers, distributors, and other stakeholders. Our client assignments can be as broad as developing comprehensive business or commercialization plans from the ground up. Additionally, we perform focused market research activities that seek to uncover subtle but impactful market trends, address issues, or identify potential opportunities. Representative assignments include: • Commercialization U.S. Marketing & Distribution – AI Imaging Apps. Launch Planning SPECT Imaging Agents Customer Outreach & Test Marketing Distributor-Pharmacy Contracting Support Organization & Resource Planning Business Development Distribution & Supply Chain Partnering – U.S. & Global • Market Research & Intelligence Imaging Agent Market (X-Ray, MRI, Nuclear) Diagnostic-Therapeutic Radioligands S/W Applications for Medical Image Processing Venous Access and IV Infusion Devices Cell Therapies (CAR-T Cell Processing and Supply Chain) Structural Heart (Valves & Occlusion Devices) Ostomy & Wound Care • Product-Project Support Early Stage Strategy & B-Plan Development Fundraising Support Regulatory (510(k), Combination Products, Imaging Agents as a Device) Product Design (Injector-Infusion Products, Software, UI/UX Development) Start-Up Mentoring While our sweet spot is the medical imaging market segment, IVMatters has successfully performed a variety of projects in the broader MedTech markets. We look forward to undertaking future assignments in support of your success.

Industry
Medical Equipment Manufacturing
Company size
1 employee
Headquarters
Huntington, New York
Type
Privately Held
Founded
2017
Specialties
Healthcare IT, Imaging Contrast Media, IV Infusion Devices and Technologies, Imaging Dose Monitoring, Product Development, Medical Consumable Products, Regulatory Affairs, Intellectual Property, Strategic Marketing, Consulting, Investment, Strategic Advisor, Business Development, Primary Market Research, and Nuclear Medicine

Locations

Employees at IVMatters

Updates

  • View organization page for IVMatters, graphic

    132 followers

    IVMatters graciously thanks and supports the President, FLOTUS, and the White House team in support of their initiatives to Advance Women's Health Research and Innovation: "Galvanize New Research on Women’s Midlife Health. To narrow research gaps on diseases and conditions associated with women’s midlife health or that are more likely to occur after menopause, such as rheumatoid arthritis, heart attack, and #osteoporosis ..." #bonehealth #menopause #wellness #joebiden #FLOTUS #whitehouse #president #bonedensity #fracturerisk #ultrasound Bob Williams

    Thank you FLOTUS and the White House Initiative on Women’s Health Research for recommending urgent improvements in care for women’s health in America and for specifically mentioning the need to address #osteoporosis. Assuring better post-fracture care for the nearly 2 million women and men who suffer fractures every year will save taxpayers $ and save lives. https://lnkd.in/erBFM2m2

    FACT SHEET: President Biden Issues Executive Order and Announces New Actions to Advance Women’s Health Research and Innovation | The White House

    FACT SHEET: President Biden Issues Executive Order and Announces New Actions to Advance Women’s Health Research and Innovation | The White House

    whitehouse.gov

  • Interesting technical content regarding the acquisition and interpretation of clinical bone densitometry...

    View profile for Bob Williams, graphic

    Helping MedTech Companies Solve Tough Problems | Focus on Medical Imaging | BD & Commercialization | Market Research & Analytics | Start-Up Launch

    On behalf of and IVMatters, we thank the International Society for Clinical Densitometry and its participating clinicians for conducting a wonderful R.T. educational venue this past weekend. As a technical marketer and developer of medical devices, I find listening to clinicians at these venues most enjoyable, enlightening, and informative. Thank you for sharing content on: Diagnosis of Osteoporosis Pediatric DXA from A-Z Review of DXA/Understanding complex scans (Hard DXA Cases) Introduction to Vertebral Fracture Assessment Why and How of Precision Cross Calibration 2023 ISCD Official Positions Basics of Hologic Basics of GE Lunar Looking forward to the April clinical venue. American Society of Radiologic Technologists, Echolight #osteoporosis #bonehealth #REMS

    • No alternative text description for this image
  • Staying busy with musculoskeletal and metabolic health.

    View profile for Bob Williams, graphic

    Helping MedTech Companies Solve Tough Problems | Focus on Medical Imaging | BD & Commercialization | Market Research & Analytics | Start-Up Launch

    Echolight looks forward to supporting its U.S. commercialization partner JUVENT at the Health and Freedom Summit in downtown Atlanta today through Sunday. https://lnkd.in/enu2cvEr Please stop by the JUVENT Health exhibit to learn how Echolight REMS can support your patient's musculoskeletal health and wellness. Echolight's ECHOs is an FDA-approved bone densitometry platform based on Radiofrequency Echographic Multi-Spectrometry (REMS) ultrasound. ECHOS is a mobile point-of-care platform providing bone densitometry, fracture risk, and body composition diagnostic reporting for your practice.   #integratedmedicine #musculoskeletalhealth #osteoporosis #Atlanta #wellness #bonehealth #REMS Juvent IVMatters Echolight

    • No alternative text description for this image
  • Moving forward with BD and Commercialization Support for Echolight SpA.

    View profile for Bob Williams, graphic

    Helping MedTech Companies Solve Tough Problems | Focus on Medical Imaging | BD & Commercialization | Market Research & Analytics | Start-Up Launch

    Echolight looks forward to supporting its U.S. commercialization partner JUVENT Health at the International College of Integrative Medicine 2024 Inflammaging Conference starting this Thursday. Echolight's ECHOs is an FDA-approved bone densitometry platform based on Radiofrequency Echographic Multi-Spectrometry (REMS) ultrasound. ECHOS is a mobile point-of-care platform providing bone densitometry, fracture risk, and body composition diagnostic reporting for your practice.   Please stop by the JUVENT Health exhibit to learn how Echolight REMS can support your patient's musculoskeletal health and wellness.   International College of Integrative Medicine #integratedmedicine #musculoskeletalhealth #osteoporosis #NewOrleans #bonehealth Juvent Echolight IVMatters

    • No alternative text description for this image
  • While osteoporosis diagnostic technology has been around since the 80s, somehow changes in lifestyles and societal healthcare keep unintended gaps in osteoporosis screening and care open. Osteoporosis and related fractures result in a $54B U.S. societal burden. We seek to provide unique and innovative solutions to alleviate this burden.

    View profile for Bob Williams, graphic

    Helping MedTech Companies Solve Tough Problems | Focus on Medical Imaging | BD & Commercialization | Market Research & Analytics | Start-Up Launch

    An interesting paper out of the Division of Gastroenterology, Hepatology, and Nutrition at the University of Minnesota. https://bit.ly/3SsHbap The authors conclude that; “A minority of patients with cirrhosis are screened for osteoporosis despite higher rates of abnormal bone density compared to the general population.” Their conclusions are based on a retrospective review of patient histories in a single health system for patients diagnosed with cirrhosis. As a lay reader, a disproportionate mismatch between the prevalence of cirrhosis related osteoporosis and diagnostic bone mineral density testing is evident. It is highlighted that the lack of bone mineral density diagnostics in cirrhosis patients can be attributed to multiple U.S. society guidelines that do not site cirrhosis as a risk factor to necessitate osteoporosis screening. Similarly, primary care providers' awareness of cirrhosis as an osteoporosis risk factor to warrant recommending screening may be low. Additionally, patient compliance for those patients in this population recommended osteoporosis screening appears sub-optimal. Echolight REMS provides an easy-to-use point-of-care ultrasound solution for osteoporosis screening. www.echolightmedical.com Please get in touch with us to learn how we can help you provide REMS bone diagnostics to your patients. #osteoporosis #BMD Echolight IVMatters #hepatology #liverdisease #cirrhosis #nash #gastroenterology #universityofminnesota

    • No alternative text description for this image
  • We Love BD & Commercialization!

    View profile for Bob Williams, graphic

    Helping MedTech Companies Solve Tough Problems | Focus on Medical Imaging | BD & Commercialization | Market Research & Analytics | Start-Up Launch

    As Echolight proceeds on its commercialization journey in support of improving bone health diagnostics in the U.S.A. with REMS (Radiofrequency Echographic Multi Spectrometry), our market research and discovery efforts revealed that successful deployment of this diagnostic modality to measure bone mineral density and associated fracture risk requires first and foremost that Echolight's U.S. Team can support: 1) Training providers on proper acquisition techniques. & 2) Helping providers effectively communicate REMS results to their patients. In pursuit of this imperative, two days of intensive training on the Echolight Echos platform was conducted at IVMatters offices. Special thanks to U.S. team members Cindy Card BA, RT (R)(M) (ARRT), and Ben Gonzalez for immersing themselves in this training that included extensive live person REMS scanning and embracing all technological details of the platform. Echolight REMS provides an easy-to-use point-of-care ultrasound solution for measuring bone mineral density and fracture risk. www.echolightmedical.com Please get in touch with us to learn how we can help you provide REMS bone diagnostics to your patients in support of optimally managing their musculoskeletal health. #osteoporosis #BMD #womenshealth #REMS #bonehealth Thanks to The Lynne Experience LTD for medical models.

    • No alternative text description for this image
  • Osteoporosis diagnostics remains an interesting learning journey. Fracture risk measurement along with body composition measurement is adding some interesting twists and turns toward improving bone health, and musculoskeletal wellness, and hopefully helping curb the incidence of debilitating fragility fractures.

    View profile for Bob Williams, graphic

    Helping MedTech Companies Solve Tough Problems | Focus on Medical Imaging | BD & Commercialization | Market Research & Analytics | Start-Up Launch

    A recently published multi-center study examines the importance of fracture risk communication as it pertains to the diagnosis and treatment of osteoporosis. https://lnkd.in/eVNicZZs The Patients’ Preferences for Fracture Risk Communication: the Risk Communication in Osteoporosis (RICO) study, concludes; “There is a significant communication gap between healthcare professionals and patients when discussing osteoporosis fracture risk.” In my recent conversations with bone health and osteoporosis clinicians, it has become readily evident that successful communication of a patient’s bone health no longer simply relies on absolute physiologic diagnostic bone mineral density measurement quantities, primarily your T & Z scores. These measured values can be communicated to the patient qualitatively in a comparable means to that of a patient’s blood chemistry measurements, i.e. your blood cholesterol (LDL) is low-high, good-bad, normal, etc. Fracture risk on the other hand is a patient’s probability of experiencing a fracture within a given period, typically 5-10 years. Fracture risk patient communication ideally needs to provide a simple means by which patients can best understand the resulting probability distribution they face such that they can make optimal care decisions. The authors conclude that optimal clinician communication of fracture risk is accomplished both with verbal consult and supporting easy-to-understand graphics that can be later referenced by the patient either on hard copy or digitally accessible report. Fracture risk is further confounded in that it can be statistically derived based solely on a patient’s demographics, or by actual measurement of the patient’s bone structure at a ROI. Echolight REMS provides an easy-to-use point-of-care ultrasound solution for measuring bone mineral density (BMD) and fracture risk (FR). www.echolightmedical.com Radiofrequency Echographic Multi Spectrometry (REMS) being radiation-free utilizes locally applied ultrasound over the femur and lumbar spine. #osteoporosis #BMD #womenshealth IVMatters Echolight International Osteoporosis Foundation Bone Health & Osteoporosis Foundation

    • No alternative text description for this image

Similar pages